表紙:神経変性疾患治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
市場調査レポート
商品コード
1028788

神経変性疾患治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)

Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
神経変性疾患治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の神経変性疾患治療薬の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し、セグメント別 (適応症の種類別、薬剤の種類別) および地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 神経変性疾患治療薬市場の特徴

第3章 神経変性疾患治療薬市場の傾向と戦略

第4章 神経変性疾患治療薬市場に対する新型コロナウイルス感染症 (COVID-19) の影響

第5章 神経変性疾患治療薬市場:市場規模・成長率

  • 市場規模 (単位:10億米ドル、2015年~2020年)
    • 市場促進要因
    • 市場抑制要因
  • 市場規模 (単位:10億米ドル、2020年~2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第6章 神経変性疾患治療薬市場:分野別の分析

  • 適応症の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • パーキンソン病
  • アルツハイマー病
  • 多発性硬化症
  • ハンチントン病
  • その他の種類の適応症
  • 薬剤の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • NMDA型グルタミン酸受容体
  • 選択的セロトニン再取り込み阻害薬 (SSRI)
  • ドーパミン阻害薬
  • その他の種類の薬剤
  • 流通経路別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 神経変性疾患治療薬市場:地域別・国別分析

  • 地域別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 国別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)

第8章 アジア太平洋の神経変性疾患治療薬市場

  • 市場概要
  • 地域情報
  • 適応症の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 薬剤の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧の神経変性疾患治療薬市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 東欧の神経変性疾患治療薬市場

第20章 ロシア市場

第21章 北米の神経変性疾患治療薬市場

第22章 米国市場

第23章 南米の神経変性疾患治療薬市場

第24章 ブラジル市場

第25章 中東の神経変性疾患治療薬市場

第26章 アフリカの神経変性疾患治療薬市場

第27章 神経変性疾患治療薬市場:競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Biogen
    • Pfizer
    • Novartis
    • Sanofi
    • Teva Pharmaceutical

第28章 神経変性疾患治療薬のパイプライン製品の分析

第29章 神経変性疾患治療薬市場における主要な企業合併・買収 (M&A)

第30章 神経変性疾患治療薬市場:将来展望と潜在力の分析

第31章 付録

目次
Product Code: h812

“Neurodegenerative Disorder Therapeutics Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global neurodegenerative disorder therapeutics market.

This report focuses on neurodegenerative disorder therapeutics market which is experiencing strong growth. The report gives a guide to the neurodegenerative disorder therapeutics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the neurodegenerative disorder therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Neurodegenerative Disorder Therapeutics market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider neurodegenerative disorder therapeutics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The neurodegenerative disorder therapeutics market section of the report gives context. It compares the neurodegenerative disorder therapeutics market with other segments of the neurodegenerative disorder therapeutics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, neurodegenerative disorder therapeutics indicators comparison.

Scope

Markets Covered:

1) By Indication Type: Parkinson's Disease; Alzheimer's Disease; Multiple Sclerosis; Huntington Disease; Other Indication Types

2) By Drug Type: N- methyl- D- aspartate Receptor; Selective Serotonin Reuptake Inhibitor; Dopamine Inhibitors; Other Drug Types

3) By Distribution: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Companies Mentioned: Biogen; Pfizer; Novartis; Sanofi; Teva Pharmaceutical

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Neurodegenerative Disorder Therapeutics Market Characteristics

3. Neurodegenerative Disorder Therapeutics Market Trends And Strategies

4. Impact Of COVID-19 On Neurodegenerative Disorder Therapeutics

5. Neurodegenerative Disorder Therapeutics Market Size And Growth

  • 5.1. Global Neurodegenerative Disorder Therapeutics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Neurodegenerative Disorder Therapeutics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Neurodegenerative Disorder Therapeutics Market Segmentation

  • 6.1. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Parkinson's Disease
  • Alzheimer's Disease
  • Multiple Sclerosis
  • Huntington Disease
  • Other Indication Types
  • 6.2. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • N- methyl- D- aspartate Receptor
  • Selective Serotonin Reuptake Inhibitor
  • Dopamine Inhibitors
  • Other Drug Types
  • 6.3. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Neurodegenerative Disorder Therapeutics Market Regional And Country Analysis

  • 7.1. Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Neurodegenerative Disorder Therapeutics Market

  • 8.1. Asia-Pacific Neurodegenerative Disorder Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Neurodegenerative Disorder Therapeutics Market

  • 9.1. China Neurodegenerative Disorder Therapeutics Market Overview
  • 9.2. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Neurodegenerative Disorder Therapeutics Market

  • 10.1. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Neurodegenerative Disorder Therapeutics Market

  • 11.1. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Neurodegenerative Disorder Therapeutics Market

  • 12.1. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Neurodegenerative Disorder Therapeutics Market

  • 13.1. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Neurodegenerative Disorder Therapeutics Market

  • 14.1. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Neurodegenerative Disorder Therapeutics Market

  • 15.1. Western Europe Neurodegenerative Disorder Therapeutics Market Overview
  • 15.2. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Neurodegenerative Disorder Therapeutics Market

  • 16.1. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Neurodegenerative Disorder Therapeutics Market

  • 17.1. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Neurodegenerative Disorder Therapeutics Market

  • 18.4. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Neurodegenerative Disorder Therapeutics Market

  • 19.1. Eastern Europe Neurodegenerative Disorder Therapeutics Market Overview
  • 19.2. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Neurodegenerative Disorder Therapeutics Market

  • 20.1. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Neurodegenerative Disorder Therapeutics Market

  • 21.1. North America Neurodegenerative Disorder Therapeutics Market Overview
  • 21.2. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Neurodegenerative Disorder Therapeutics Market

  • 22.1. USA Neurodegenerative Disorder Therapeutics Market Overview
  • 22.2. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Neurodegenerative Disorder Therapeutics Market

  • 23.1. South America Neurodegenerative Disorder Therapeutics Market Overview
  • 23.2. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Neurodegenerative Disorder Therapeutics Market

  • 24.1. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Neurodegenerative Disorder Therapeutics Market

  • 25.1. Middle East Neurodegenerative Disorder Therapeutics Market Overview
  • 25.2. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Neurodegenerative Disorder Therapeutics Market

  • 26.1. Africa Neurodegenerative Disorder Therapeutics Market Overview
  • 26.2. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles

  • 27.1. Neurodegenerative Disorder Therapeutics Market Competitive Landscape
  • 27.2. Neurodegenerative Disorder Therapeutics Market Company Profiles
    • 27.2.1. Biogen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Pfizer
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Sanofi
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Teva Pharmaceutical
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Neurodegenerative Disorder Therapeutics Pipeline Analysis

29. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market

30. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer